Crossref
Adjuvant Docetaxel and Abbreviated Androgen Deprivation Therapy in Patients with High Risk Prostate Cancer
The Open Prostate Cancer Journal · 2010
DOI: 10.2174/1876822901003010099 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Open Prostate Cancer Journal, 2010. Verfasst von Jose G. Bazan und 3 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Bazan, J. G., King, C. R., Brooks, J. D., & Srinivas, S. (2010). Adjuvant Docetaxel and Abbreviated Androgen Deprivation Therapy in Patients with High Risk Prostate Cancer. The Open Prostate Cancer Journal. https://doi.org/10.2174/1876822901003010099
Vancouver
Bazan JG, King CR, Brooks JD, Srinivas S. Adjuvant Docetaxel and Abbreviated Androgen Deprivation Therapy in Patients with High Risk Prostate Cancer. The Open Prostate Cancer Journal. 2010. doi:10.2174/1876822901003010099
BibTeX
@article{Bazan2010,
author = {Bazan, Jose G. and King, Christopher R. and Brooks, James D. and Srinivas, Sandy},
title = {Adjuvant Docetaxel and Abbreviated Androgen Deprivation Therapy in Patients with High Risk Prostate Cancer},
journal = {The Open Prostate Cancer Journal},
year = {2010},
doi = {10.2174/1876822901003010099}
}
EUVIMED